• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[马里埃尔共和国结核分枝杆菌耐药性监测]

[Monitoring of drug resistance in Mycobacterium tuberculosis in The Republic of Mariy El].

作者信息

Sevast'ianova E V, Petrova L V

出版信息

Probl Tuberk Bolezn Legk. 2008(9):13-6.

PMID:19065732
Abstract

Drug resistance (DR) in Mycobacterium tuberculosis (MBT) has been monitored in the Republic of Mariy El. It has been established that there is a considerable prevalence of drug-resistance strains even among new cases. There is a gradual rise in the level of MBT DR, including multiple DR (MDR). In 2000 and 2006, the rates of primary MBT DR were 26.7 and 31.5% (including those of MDR were 10.2 and 13%), respectively. The proportion of strains resistant to 4 major antituberculous drugs (I, R, S, E) of the number of DR cultures increased from 19% in 2003 to 35% in 2005, which suggests the situation of high strain with the prevalence of DR tuberculosis in the Republic of Mariy El.

摘要

马里埃尔共和国一直在监测结核分枝杆菌(MBT)的耐药性。已确定即使在新发病例中,耐药菌株的患病率也相当高。MBT耐药水平,包括多重耐药(MDR),呈逐渐上升趋势。2000年和2006年,原发性MBT耐药率分别为26.7%和31.5%(其中MDR分别为10.2%和13%)。对4种主要抗结核药物(异烟肼、利福平、链霉素、乙胺丁醇)耐药的菌株在耐药培养菌株中的比例从2003年的19%增至2005年的35%,这表明马里埃尔共和国存在耐多药结核病高发的情况。

相似文献

1
[Monitoring of drug resistance in Mycobacterium tuberculosis in The Republic of Mariy El].[马里埃尔共和国结核分枝杆菌耐药性监测]
Probl Tuberk Bolezn Legk. 2008(9):13-6.
2
[Primary drug resistance in Mycobacterium tuberculosis among patients with pulmonary tuberculosis and its impact on permanent disability in the Volgograd region].[伏尔加格勒地区肺结核患者中结核分枝杆菌的原发性耐药性及其对永久性残疾的影响]
Probl Tuberk Bolezn Legk. 2007(12):28-30.
3
[Drug resistance in Mycobacteria tuberculosis in the Barents region of Russia and Norway].
Probl Tuberk. 2002(2):41-3.
4
[Drug resistance of Mycobacterium tuberculosis in the North-West of Russia].[俄罗斯西北部结核分枝杆菌的耐药性]
Probl Tuberk Bolezn Legk. 2003(5):42-5.
5
[Drug resistance of Mycobacterium tuberculosis of the genotype Beijing in imprisonment places in the Arkhangelsk Region].[阿尔汉格尔斯克地区监禁场所中北京基因型结核分枝杆菌的耐药性]
Probl Tuberk Bolezn Legk. 2004(8):35-41.
6
[Polymerase chain reaction to determine and control drug-resistant Mycobacterium tuberculosis strains].
Probl Tuberk Bolezn Legk. 2008(4):38-44.
7
[Mycobacterium tuberculosis resistance in newly diagnosed patients and in patients with disease relapse].新诊断患者及疾病复发患者中的结核分枝杆菌耐药性
Probl Tuberk Bolezn Legk. 2003(5):19-21.
8
[Monitoring of drug resistance in Mycobacterium tuberculosis in the Republic of Sakha (Yakutia)].
Probl Tuberk Bolezn Legk. 2007(7):30-3.
9
[Analysis of risk factors of the occurrence of drug resistance in patients with tuberculosis from civil and penitentiary sectors in the Samara Region].
Probl Tuberk Bolezn Legk. 2005(5):25-31.
10
[Drug-resistant tuberculosis in the Republic of Karelia].[卡累利阿共和国的耐药结核病]
Probl Tuberk Bolezn Legk. 2007(8):8-10.